7
total announcements
541304.BO · 15 min delayed
Indo Us Bio-Tech Ltd
Indo Us Bio-Tech Ltd has announced the notice of its 22nd Annual General Meeting (AGM) to be held on September 30, 2026, through video conferencing or other digital means, as published in a newspaper.
Indo Us Bio-Tech Ltd
Indo Us Bio-Tech Ltd has announced the submission of a newspaper advertisement for its unaudited quarterly standalone financial results for the quarter ended June 30, 2026, as required by SEBI LODR Regulations.
Indo Us Bio-Tech Ltd
Indo Us Bio-Tech Ltd has announced its financial results for the quarter ended June 30, 2026, with a net profit of ₹307.70, up from ₹237.82 in the previous quarter. The company's total comprehensive income is ₹303.74, and its equity share capital is ₹2,005.20. The financial results were approved by the Board of Directors and reviewed by the Statutory Auditors.
Indo Us Bio-Tech Ltd
Indo Us Bio-Tech Ltd has announced the outcome of its board meeting held on August 12, 2026, where the board approved unaudited financial results for the quarter ended June 30, 2026, along with limited review reports from the auditor.
Indo Us Bio-Tech Ltd
Indo Us Bio-Tech Ltd has announced the outcome of its postal ballot, where shareholders voted on certain resolutions through remote e-voting. The voting results have been declared, and the outcome will be communicated to the stock exchanges and other stakeholders.
Indo Us Bio-Tech Ltd
Indo Us Bio-Tech Ltd has announced the results of its postal ballot, where shareholders have passed two resolutions: the regularization of the appointment of Mrs. Hemanshi Darsh Soni as an additional director and the appointment of M/s. Bhagat & Associates as the statutory auditor. The voting period commenced on July 5, 2026, and concluded on August 3, 2026. The resolutions were passed with 100% and 99.9983% of the votes, respectively.
Indo Us Bio-Tech Ltd
Indo Us Bio-Tech Ltd has scheduled a Board meeting on 12th August 2026 to consider unaudited financial results for the quarter ended 30th June 2026 and other corporate matters.